I looked at (10) published TSI patents and applied a 6 month public review period that we may have an idea when upcoming patents MIGHT issue. Here they are in chronological order, potentially soonest to issue to last. This doesn’t account for complexity, as that often affects the length of review. It’s an academic exercise, although, provides some insight as to what’s “coming down the pipe”.
1) Nutraceuticals for Reducing Myeloid Suppressor Cells
- Filed 6/11/20….Published 12/16/21
Est Issuance date = 6/16/22
2) Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
- Filed 6/22/20….Published 12/23/21
Est Issuance date = 6/23/22
3) Additive and/or Synergistic Combinations of Metformin with Nutraceuticals for the Prevention, Inhibition and Treatment of SARS-Cov-2 and Associated COVID-19
- Filed 7/22/2020….Published 1/27/22
Est Issuance 7/27/22
4) Neuroprotection and Neuroregeneration by Pterostilbene
- Filed 7/28/2020….Published 2/3/22
Est Issuance 8/3/22
5) Prevention of Neuroinflammation associated Memory Loss Using Nutraceutical Compositions
- Filed 8/5/2020….Published 2/10/22
Est Issuance 8/10/22
6) Methods of Determining Risk of Suicide and/or Suicidal Ideation by Immunological Assessment
- Filed 8/21/2020….Published 2/24/22
Est Issuance 8/24/22
7) Upregulation of Therapeutic T Regulatory Cells and Suppression of Suicidal Ideations in Response to Inflammation by Administration of Nutraceutical Compositions Alone or Combined with Minocycline
- Filed 8/28/2020….Published 3/3/22
Est Issuance 9/3/22
8) Personalized Immunotherapies for Reduction of Brain Inflammation and Suicide Prevention
- Filed 9/24/2020….Published 3/24/22
Est Issuance 9/6/22
9) Augmentation of Natural Killer Cell Activity and Induction of Cytotoxic Immunity Using Leukocyte Lysate Activated Allogeneic Dendritic Cells: StemVacs™
- Filed 6/30/2020….Published 3/31/22
Est Issuance 9/31/22
10) CELLULAR, ORGAN, AND WHOLE-BODY REJUVENATION UTILIZING CORD BLOOD PLASMA AND PTEROSTILBENE
- Filed 11/4/2020…Published 5/6/2021
Est Issuance 11/6/22
(Please forgive/feel free to correct any unintended typos/errors Tim